Profil
Dr. Marco Verwijs is an Executive Vice President-Technical Operations at CervoMed, Inc. Dr. Verwijs was previously employed as a Chief Technical Officer by Aerovate Therapeutics, Inc., a Chief Technical Officer by Adipo Therapeutics LLC, and a Chief Technology Officer by Aerovate Therapeutics, Inc. He received his graduate degree from Delft University of Technology and a doctorate degree from the University of Florida.
Aktiva positioner av Marco Verwijs
| Företag | Position | Start |
|---|---|---|
| CERVOMED INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-06-01 |
Tidigare kända positioner av Marco Verwijs
| Företag | Position | Slut |
|---|---|---|
| JADE BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-07-01 |
| JADE BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Adipo Therapeutics LLC
Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Teknisk/Vetenskaplig/F&U Direktör | - |
Marco Verwijss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Adipo Therapeutics LLC
Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Health Technology |
CervoMed, Inc.
CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
















